Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

Volume: 375, Issue: 25, Pages: 2423 - 2434
Published: Nov 14, 2016
Abstract
BackgroundIn patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI) with placement of stents, standard anticoagulation with a vitamin K antagonist plus dual antiplatelet therapy (DAPT) with a P2Y12 inhibitor and aspirin reduces the risk of thrombosis and stroke but increases the risk of bleeding. The effectiveness and safety of anticoagulation with rivaroxaban plus either one or two antiplatelet agents are...
Paper Details
Title
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
Published Date
Nov 14, 2016
Volume
375
Issue
25
Pages
2423 - 2434
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.